Ted Murphy

CIK: 0001685432

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (40.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CODX

Co-Diagnostics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

CODX
Co-Diagnostics, Inc.
Aug 13, 2025
Award(A)
Restricted Stock Units
Direct
125K shares-
CODX
Co-Diagnostics, Inc.
May 23, 2025
Award(A)
Direct
48.3K shares-
CODX
Co-Diagnostics, Inc.
May 23, 2025
Exercise(M)
Restricted Stock Unit
Direct
48.3K shares-
CODX
Co-Diagnostics, Inc.
Nov 23, 2024
Award(A)
Direct
48.3K shares-
CODX
Co-Diagnostics, Inc.
Nov 23, 2024
Exercise(M)
Restricted Stock Unit
Direct
48.3K shares-

		Type	Shares	Price		Ownership
Aug 13, 2025	CODX Co-Diagnostics, Inc.	Award(A) Restricted Stock Units	125,000	-	-	Direct
May 23, 2025	CODX Co-Diagnostics, Inc.	Award(A)	48,334	-	-	Direct
May 23, 2025	CODX Co-Diagnostics, Inc.	Exercise(M) Restricted Stock Unit	48,334	-	-	Direct
Nov 23, 2024	CODX Co-Diagnostics, Inc.	Award(A)	48,333	-	$0	Direct
Nov 23, 2024	CODX Co-Diagnostics, Inc.	Exercise(M) Restricted Stock Unit	48,333	-	-	Direct

1-5 of 5 transactions

About MURPHY TED

MURPHY TED (SEC CIK 0001685432) files insider reports with the SEC as Director of Co-Diagnostics, Inc. (CODX).

Signal8 holds 3 ownership filings by MURPHY TED, all Form 4s, filed between Nov 25, 2024 and Aug 15, 2025. Those filings report 5 transactions, from Nov 23, 2024 to Aug 13, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on MURPHY TED's filings is in SALT LAKE CITY, UT.

Recent filings by MURPHY TED

Aug 13, 2025: Grant or award of CODX derivative securities (Form 4, code A).
May 23, 2025: Grant or award of CODX shares (Form 4, code A).
May 23, 2025: Option exercise of CODX derivative securities (Form 4, code M).
Nov 23, 2024: Grant or award of CODX shares (Form 4, code A).
Nov 23, 2024: Option exercise of CODX derivative securities (Form 4, code M).

Other insiders filing for Co-Diagnostics, Inc. (CODX)

Bohrer Daniel, EVP of Finance & Accounting
Egan Dwight H, Chief Executive Officer
Brown Brian Lee, Chief Financial Officer
Abbott Richard David, President
Murphy Edward L., Director
SERBIN RICHARD S, Director

How to read Form 4 transaction codes